Why non-diabetics using CGM may not be a good idea

A clinical trial has found that a continuous glucose monitor device systemically overestimated blood glucose levels when used by non-diabetic people.

Abbott’s OTC glucose monitor ‘will grow the market’

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its

FDA clears first OTC glucose biosensor, from Dexcom

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time.

Lilly doubles down on Dexcom tech for connected insulin devi...

Lilly looks to devices to revive diabetes division

Dexcom continuous glucose monitors to become part of Lilly's Connected Devices Ecosystem.

Fitbit and Dexcom to bring diabetes data to Ionic smartwatch

Dexcom G5 Mobile data will be displayed on Fitbit's Ionic smartwatch.